North America Virology Market Analysis, Size, and Share by 2028
North America Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)
- Report Date : Nov 2021
- Report Code : TIPRE00025739
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 178
The virology market in North America is expected to grow from US$ 1,531.21 million in 2021 to US$ 1,984.33 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028.
The US, Canada, and Mexico are economies in North America. Viral infection is among the leading causes of human chronic diseases. A few viruses, such as human immunodeficiency virus (HIV), flu virus, Zika, Diphtheria, Ebola, SARS-CoV-2 (COVID-19), Polio, and Tetanus (Lockjaw), infect large populations across the world. As virus mutate and evolve continuously, drug resistance become an impending challenge for viral infection management among the human and animals. A virus transmits through various mediums based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, transmits through droplets generated through coughing or sneezing, while some because gastrointestinal viral diseases transmitted through feces contaminated food or water. The novel coronavirus that causes COVID-19 was identified in 2019. The International Committee on Taxonomy of Viruses (ICTV) declared the virus as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on February 11, 2020, and later WHO named the disease as COVID-19. The virus has undergone mutation a couple of times since its outbreak, which has added to the severity of the COVID-19 pandemic. Therefore, the rising prevalence of viral infections drives the growth of the North America virology market.North America has experienced a rising number of cases of COVID-19 since its outbreak. The cases are also increasing in countries such as Mexico and Canada in the region. As COVID19 is a novel virus and had no established treatment methods, no vaccines, drugs specific to the virus were not available. Thus, it was a potential opportunity for product innovation and development to the market players operating in the virology-related business. The governments have extensively invested in and promoted vaccine development and prioritized the easy and quick approval process. Regional and international players launch various virus products such as rapid test kits, vaccines, and others. And the large-scale production of these products and rising demand are expected to have a favorable impact on the virology-related market in the region. However, the end-users' panic buying and stocking of the products are expected to cause a loss in terms of product expiry. Thus, such factors are expected to have a negative impact on the related market in the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The North America virology market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
North America Virology Market Segmentation
North America Virology Market – By Type
- Diagnostic Test
- DNA Virus Testing
- RNA Virus Testing
- Others
- Viral Infection Controlling Techniques
- Active Prophylaxis
- Passive Prophylaxis
- Antiviral Therapeutics
- Virucidal Agents
- Antiviral Agents
- Immunomodulators
- Interferons
North America Virology Market – By Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Others
North America Virology Market – By End User
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical and Biotechnological Companies
- Research and Academic Institutes
North America Virology Market- By Country
- US
- Canada
- Mexico
North America Virology Market-Companies Mentioned
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo fisher scientific inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Virology Market – By Type
1.3.2 North America Virology Market – By Application
1.3.3 North America Virology Market – By End User
1.3.4 North America Virology Market– By Country
2. North America Virology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Virology Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Virology Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Viral Infectious Diseases
5.1.2 Increasing Product Launches
5.2 Market Restraints
5.2.1 Availability of Alternative Products and High Cost of Production of Products
5.3 Market Opportunities
5.3.1 Tremendous Growth Potential in Several Economies
5.4 Future Trends
5.4.1 Continuous Requirement for Cost-Effective Products
5.5 Impact Analysis
6. Virology Market– North America Analysis
6.1 North America Virology Market Revenue Forecast and Analysis
7. North America Virology Market Analysis – By Type
7.1 Overview
7.2 North America Virology Market Revenue Share, by Type (2021 and 2028)
7.3 Diagnostic Test
7.3.1 Overview
7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing
7.3.2.1.1 Overview
7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Ribonucleic Acid (RNA) Virus Testing
7.3.2.2.1 Overview
7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Others
7.3.2.3.1 Overview
7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Viral Infection Controlling Techniques
7.4.1 Overview
7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.1 Active Prophylaxis
7.4.2.1.1 Overview
7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.2.2 Passive Prophylaxis
7.4.2.2.1 Overview
7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Antiviral Therapeutics
7.5.1 Overview
7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.1 Virucidal Agents
7.5.2.1.1 Overview
7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.2 Antiviral Agents
7.5.2.2.1 Overview
7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.2.3 Immunomodulators
7.5.2.3.1 Overview
7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Interferons
7.6.1 Overview
7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Virology Market Analysis – By Application
8.1 Overview
8.2 North America Virology Market, by Application 2021 & 2028 (%)
8.3 Skin and Soft Tissue Infections
8.3.1 Overview
8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Tract Infections
8.4.1 Overview
8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 GI Tract Infections
8.5.1 Overview
8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sexually Transmitted Diseases
8.6.1 Overview
8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Virology Market Analysis – By End User
9.1 Overview
9.2 North America Virology Market Revenue Share, by End User (2021 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pharmaceutical and Biotechnological Companies
9.5.1 Overview
9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Research and Academic Institutes
9.6.1 Overview
9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Virology Market – Country Analysis
10.1.1 Overview
10.1.2 North America: Virology Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Virology Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.1.3.1 US: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.1.3.2 US: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.1.3.3 US: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.1.4 US: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.1.5 US: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.2.3.1 Canada: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.2.3.2 Canada: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.2.3.3 Canada: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.2.4 Canada: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.2.5 Canada: Virology Market, by End User, 2019–2028 (USD Million)
10.1.2.3 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico: Virology Market, by Type, 2019–2028 (USD Million)
10.1.2.3.3.1 Mexico: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)
10.1.2.3.3.2 Mexico: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)
10.1.2.3.3.3 Mexico: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)
10.1.2.3.4 Mexico: Virology Market, by Application, 2019–2028 (USD Million)
10.1.2.3.5 Mexico: Virology Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on North America Virology Market
11.1 Overview
12. North America Virology Market–Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Johnson and Johnson Services, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. HOFFMANN-LA ROCHE LTD.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 QIAGEN
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Illumina, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 GlaxoSmithKline Plc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AbbVie Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Gilead Sciences, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Virology Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. US Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Virology Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Virology Market, by Diagnostic Test – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Virology Market, by Viral Infection Controlling Techniques – Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Virology Market, by Antiviral Therapeutics – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico: Virology Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, North America Virology Market
LIST OF FIGURES
Figure 1. North America Virology Market Segmentation
Figure 2. North America Virology Segmentation, By Country
Figure 3. North America Virology Market Overview
Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in North America Virology Market
Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in North America Virology Market
Figure 6. US to Show Significant Growth During Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Virology Market: Impact Analysis of Drivers and Restraints
Figure 9. North America Virology Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Virology Market Revenue Share, by Type (2021 and 2028)
Figure 11. North America Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Virology Market, by Application 2021 & 2028 (%)
Figure 24. North America Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. North America Virology Market Revenue Share, by End User (2021 and 2028)
Figure 31. North America Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Virology Market, by Key Country – Revenue (2021) (USD Million)
Figure 36. North America: Virology Market, by Country, 2021 & 2028 (%)
Figure 37. US: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Canada: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Mexico: Virology Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in North American Country Markets
- Abbott
- AbbVie Inc.
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Illumina, Inc.
- Johnson and Johnson Services, Inc.
- QIAGEN
- Siemens AG
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Nov 2021
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Nov 2021
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Nov 2021
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Nov 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Nov 2021
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Nov 2021
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For